$59.00
Group Buy Price: $54
brand:
NEURAMIS®
manufacturer:
Medytox Inc
active substances:
HYALURONIC ACID, LIDOCAINE
strength:
20mg/ml HA, 3mg/ml Lidocaine
pack size:
1 x 1ml Pre-Filled Syringes
NEURAMIS® VOLUME with Lidocaine is a high-viscosity hyaluronic acid (HA) dermal filler tailored for deep facial augmentation and contouring. It is intended for patients seeking enhancement in areas requiring long-lasting volume and definition, such as the cheeks, chin, and nasolabial folds. Utilizing Medytox’s exclusive SHAPE (Stabilized Hyaluronic Acid and Purification Enhancement) technology, NEURAMIS® VOLUME offers robust stability and cohesiveness, while the inclusion of lidocaine ensures patient comfort during treatment.
Key Features:
NEURAMIS® VOLUME with Lidocaine is ideal for deep dermal and subcutaneous augmentation, providing lift and structure in areas with significant volume loss or in need of contouring. This filler suits individuals seeking pronounced facial definition.
Primary Indications:
NEURAMIS® VOLUME with Lidocaine is administered in targeted doses according to the patient’s desired outcomes and the treatment area. The injection process requires careful technique to achieve a natural and balanced look.
Treatment Protocol:
NEURAMIS® VOLUME with Lidocaine is generally well-tolerated due to the biocompatibility of hyaluronic acid and the addition of lidocaine for pain relief. Nonetheless, minor side effects may occur at the injection site.
Common Side Effects:
Precautions:
NEURAMIS® VOLUME with Lidocaine has demonstrated efficacy and durability in treating volume loss and enhancing facial contours. Clinical studies emphasize the filler’s sustained results and high patient satisfaction.
Key Findings:
Clinical Observations:
NEURAMIS® VOLUME with Lidocaine is composed of hyaluronic acid cross-linked through SHAPE technology, which enhances its durability and stability in the tissue.
Key Ingredients:
NEURAMIS® VOLUME with Lidocaine has low systemic absorption, but certain drug interactions may still impact treatment outcomes, especially in sensitive patients.
Important Considerations: